Skip to content

Price / book at other companies

Illumina logo
IlluminaILMN
+1.7×
Revvity logo
RevvityRVTY
1.4×-0.3×
Maravai LifeSciences Holdings, Inc. logo
Maravai LifeSciences Holdings, Inc.MRVI
+0.9×
Agilent Technologies logo
Agilent TechnologiesA
4.6×-0.4×
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
3.5×-0.3×
Twist Bioscience Corporation logo
Twist Bioscience CorporationTWST
6.4×+1.1×

Other financials

Income statement

See full
Revenue$37.2M+0.1%
Gross profit$12.8M+1,037%
Operating income-$8.4M+98.1%
Net income-$8.3M+98.1%
EPS (diluted)-$0.03+97.9%

Balance sheet

See full
Cash & equivalents$57.9M-4.7%
Total debt$59.3M+12.1%
Total equity$2.4M-97.4%
Total assets$782.4M-9.1%

Cash flow

See full
Operating cash flow-$44.7M-1.4%
CapEx$3.0M+119%
Free cash flow-$47.7M-5.0%

Valuation

See full
Market cap$496.96M+30.4%
Enterprise value$498.38M+33.5%
P/S3.1×+0.6×

Profitability

See full
Gross margin37.5%+21.3pp
Operating margin-83.3%-38.2pp
Net margin-80.3%-36.1pp
FCF margin-72.6%-20.0pp

Returns & leverage

See full
Return on equity-273.6%+314pp
Debt / equity25.1×+24.5×
Current ratio5.7×-1.0×

Where this comes from

Calculated from Pacific Biosciences of California’s reported figures.

Based on the most recent quarter.

The official record: Pacific Biosciences of California’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pacific Biosciences of California's price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Pacific Biosciences of California's price / book?
Pacific Biosciences of California (PACB) reported price / book of 168.5× in Q1 2026.
How has Pacific Biosciences of California's price / book changed year-over-year?
Pacific Biosciences of California's price / book increased by 4292.9% year-over-year, from 3.8× to 168.5×.
What is the long-term trend for Pacific Biosciences of California's price / book?
Over 5 years (2020 to 2025), Pacific Biosciences of California's price / book has grown at a 47.7% compound annual growth rate (CAGR), from 15× to 105.5×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.